Study of Aerobic Training for People Receiving Chemotherapy for Breast Cancer

Description

In this study, investigators will compare standard Aerobic Training/AT with adaptive Aerobic Training/AT. Standard AT will be a fixed (unchanging) amount of walking each week, while adaptive AT will adjust the level of exercise depending on participants' response to the exercise. Investigators will see how both study approaches (standard AT and adaptive AT) affect participants' CRF.

Conditions

Breast Cancer, Breast Carcinoma

Study Overview

Study Details

Study overview

In this study, investigators will compare standard Aerobic Training/AT with adaptive Aerobic Training/AT. Standard AT will be a fixed (unchanging) amount of walking each week, while adaptive AT will adjust the level of exercise depending on participants' response to the exercise. Investigators will see how both study approaches (standard AT and adaptive AT) affect participants' CRF.

Phase 2 Trial of Adaptive Versus Standard Dosing of Aerobic Training in Patients Receiving Chemotherapy for Primary Breast Cance

Study of Aerobic Training for People Receiving Chemotherapy for Breast Cancer

Condition
Breast Cancer
Intervention / Treatment

-

Contacts and Locations

Basking Ridge

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States, 07920

Middletown

Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States, 07748

Montvale

Memorial Sloan Kettering Bergen (Limited protocol activities), Montvale, New Jersey, United States, 07645

Commack

Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack, New York, United States, 11725

Harrison

Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States, 10604

New York

Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States, 10065

Rockville Centre

Memorial Sloan Kettering Nassau (Limited protocol activities), Rockville Centre, New York, United States, 11553

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Aged ≥18 years
  • * Female
  • * Diagnosed with primary breast cancer as defined by one of the following:
  • * Histological confirmation
  • * As per standard of care imaging
  • * Scheduled to receive neoadjuvant/adjuvant chemotherapy
  • * Performing ≤90 minutes of moderate- and/or strenuous-intensity exercise per week, as evaluated by self-report
  • * Willingness to comply with all study-related procedures
  • * Able to achieve an acceptable peak baseline CPET, as defined by any of the following criteria:
  • 1. Achieving a plateau in oxygen consumption, concurrent with an increase in power output;
  • 2. A respiratory exchange ratio ≥ 1.10;
  • 3. Attainment of maximal predicted heart rate (HRmax) (i.e., within 10 bpm of age-predicted HRmax \[HRmax = 220-Age\[years\]);
  • 4. Volitional exhaustion, as measured by a rating of perceived exertion (RPE) ≥ 18 on the BORG scale.
  • * Enrollment onto any other interventional investigational study, except interventions determined by the PI not to confound study outcomes
  • * Receiving treatment for any other diagnosis of invasive cancer
  • * Distant metastatic malignancy of any kind
  • * Mental impairment leading to inability to cooperate
  • * Any of the following contraindications to cardiopulmonary exercise testing:
  • * Any other condition or intercurrent illness that, in the opinion of the investigator, makes the subject a poor candidate for study participation

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

Memorial Sloan Kettering Cancer Center,

Jessica Scott, PhD, PRINCIPAL_INVESTIGATOR, Memorial Sloan Kettering Cancer Center

Study Record Dates

2028-01-30